InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-10 · accession 0001127602-21-029039 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-12 2021-11-10 GILD Dickinson Andrew D CFO F - Tax $67.32 -870 38.0K -2% -$58.6K
D 2021-11-12 2021-11-10 GILD Dickinson Andrew D CFO M - OptEx — +1,913 38.9K +5% —
D 2021-11-12 2021-11-10 GILD Dickinson Andrew D CFO M - OptEx — -1,913 37.4K -5% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-10 F D 870 $67.32 38,015 D — —
2 Common Common Stock 2021-11-10 M A 1,913 — 38,885 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.
3 Derivative Restricted Stock Unit 2021-11-10 M D 1,913 — 37,377 D — · — to — 1,913 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. (F2) The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.